🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Iris Tumor

Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer NCT06184698Phase 21 site📍 Shijiazhuang Hebei Medical University Fourth Hospital · Tests: liposomal irinotecan, 5-FU, LV, Bevacizumab Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer NCT05806931Phase 29 sites📍 Elizabeth📍 Jersey City📍 Lakewood Rutgers, The State University of New Jersey · Tests: TAS-102, oxaliplatin, irinotecan with bevacizumab Observational Study of Iris Tumors NCT03809585n/a1 site📍 Portland Oregon Health and Science University Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . NCT05927857Phase 1, Phase 21 site📍 Taipei National Health Research Institutes, Taiwan · Tests: nal-IRI /Experimental, Ramucirumab /Experimental, Trifluridine/Tipiracil /Experimental Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers NCT07060014Phase 12 sites📍 Houston📍 Houston The Methodist Hospital Research Institute · Tests: Patients will be treated with NALIRIFOX (liposomal irinotecan 50 mg/m2 + 5-FU 2400 mg/m2 + LV 400 mg/m2 + oxaliplatin 6… Physical Activity and Community EmPOWERment Project NCT06740162NA2 sites📍 Fayetteville📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: PACE Program Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients NCT06662006Phase 21 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: nal-IRI,5-fu,LV, benmelstobart, anlotinib Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial NCT05744219Phase 31 site📍 Uppsala Jon Unosson · Tests: Ferric carboxymaltose, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy